2020-02-26 最新期刊文獻

-
本日新增34篇文獻。新加坡學者提醒非接觸式手持皮膚紅外線測溫儀器可能因操作不正確、或離皮膚太遠等影響測量正確性，而影響篩檢效果(1)。匈牙利學者提出利用中國提出利用中國封城區域外的累積病例數、各國與中國往來頻繁程度和內部防疫政策效力來建立風險評估模式(2)。上海交大學者表示某些患者最初表現會以腸胃道症狀表現，並發現某些患者的糞便樣本和肛門試驗中會發現病毒核酸反應(6)。美國國家衛生研究院學者認為ACE2和新型冠狀病毒感染有關(13,14)，另在藥物選擇方面，推測Remdesivir和3CLpro-1應可用於直接治療新冠肺炎(17)。由於目前病毒核酸檢驗容易出現偽陰性結果，因此浙大學者分享52例確診患者胸部CT影像資訊，發現CT影像會隨著病情進展出現一定特點的動態變化，因此建議在發燒檢疫門診或針對可能感染者，進一步透過胸部CT影像來篩檢以提高診斷準確度(25)。

  1. Aw DJ. (2020). The non-contact handheld cutaneous infra-red thermometer for fever screening during the COVID-19 global emergency.  Journal of Hospital Infection, doi:10.1016/j.jhin.2020.02.010, https://doi.org/10.1016/j.jhin.2020.02.010 (需訂閱)
  2. Boldog P, Tekeli T, Vizi Z, Denes A, Bartha FA & Rost G. (2020). Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China.  Journal of Clinical Medicine, 9, doi:10.3390/jcm9020571, https://doi.org/10.3390/jcm9020571 
  3. Bonilla-Aldana DK, Quintero-Rada K, Montoya-Posada JP, Ramirez-Ocampo S, Paniz-Mondolfi A, Rabaan AA, et al. (2020). SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? - A bibliometric analysis.  Travel Medicine & Infectious Disease, 33, 101566. doi:10.1016/j.tmaid.2020.101566, https://doi.org/10.1016/j.tmaid.2020.101566 
  4. Deng SQ & Peng HJ. (2020). Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.  Journal of Clinical Medicine, 9, doi:10.3390/jcm9020575, https://doi.org/10.3390/jcm9020575 
  5. Feng ZH, Cheng YR, Chen J, Ye L, Zhou MY & Wang MW. (2020). Chinese medical personnel against the 2019-nCoV.  Journal of Infection, doi:10.1016/j.jinf.2020.02.011, https://doi.org/10.1016/j.jinf.2020.02.011 (需訂閱)
  6. Gao QY, Chen YX & Fang JY. (2020). 2019 novel coronavirus infection and gastrointestinal tract.  Journal of Digestive Diseases, doi:10.1111/1751-2980.12851, https://doi.org/10.1111/1751-2980.12851 
  7. Goh GK, Dunker AK, Foster JA & Uversky VN. (2020). Rigidity of the Outer Shell Predicted by a Protein Intrinsic Disorder Model Sheds Light on the COVID-19 (Wuhan-2019-nCoV) Infectivity.  Biomolecules, 10, doi:10.3390/biom10020331, https://doi.org/10.3390/biom10020331 
  8. Gordon CJ, Tchesnokov EP, Feng JY, Porter DP & Gotte M. (2020). The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.  Journal of Biological Chemistry, doi:10.1074/jbc.AC120.013056, https://doi.org/10.1074/jbc.AC120.013056 
  9. Hao W. (2020). Clinical Features of Atypical 2019 Novel Coronavirus Pneumonia with an initially Negative RT-PCR Assay.  Journal of Infection, doi:10.1016/j.jinf.2020.02.008, https://doi.org/10.1016/j.jinf.2020.02.008 (需訂閱)
  10. Kooraki S, Hosseiny M, Myers L & Gholamrezanezhad A. (2020). Coronavirus Outbreak: What the Department of Radiology Should Know.  Journal of the American College of Radiology, doi:10.1016/j.jacr.2020.02.008, https://doi.org/10.1016/j.jacr.2020.02.008 
  11. Kwok KO, Wong V, Wei VWI, Wong SYS & Tang JW. (2020). Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread.  Journal of Infection, doi:10.1016/j.jinf.2020.02.002, https://doi.org/10.1016/j.jinf.2020.02.002 
  12. Lai A, Bergna A, Acciarri C, Galli M & Zehender G. (2020). Early Phylogenetic Estimate of the Effective Reproduction Number Of Sars-CoV-2.  Journal of Medical Virology, doi:10.1002/jmv.25723, https://doi.org/10.1002/jmv.25723 
  13. Letko M, Marzi A & Munster V. (2020). Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.  Nature Microbiology, doi:10.1038/s41564-020-0688-y, https://doi.org/10.1038/s41564-020-0688-y 
  14. Li R, Qiao S & Zhang G. (2020). Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV.  Journal of Infection, doi:10.1016/j.jinf.2020.02.013, https://doi.org/10.1016/j.jinf.2020.02.013 (需訂閱)
  15. Lucchese G. (2020). Epitopes for a 2019-nCoV vaccine.  Cellular & Molecular Immunology, doi:10.1038/s41423-020-0377-z, https://doi.org/10.1038/s41423-020-0377-z (需訂閱)
  16. Ma FH, Hu HT & Tian YT. (2020). 新型冠狀病毒肺炎疫情期間消化系統惡性腫瘤的外科診治策略 [Surgical treatment strategy for digestive system malignancies during the outbreak of novel coronavirus pneumonia].  Chung-Hua Chung Liu Tsa Chih [Chinese Journal of Oncology], 42, E001. doi:10.3760/cma.j.cn112152-20200223-00117, https://doi.org/10.3760/cma.j.cn112152-20200223-00117 
  17. Morse JS, Lalonde T, Xu S & Liu WR. (2020). Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV.  Chembiochem, doi:10.1002/cbic.202000047, https://doi.org/10.1002/cbic.202000047 
  18. Park SC & Park YC. (2020). Mental Health Care Measures in Response to the 2019 Novel Coronavirus Outbreak in Korea.  Psychiatry Investigation, 17, 85-86. doi:10.30773/pi.2020.0058, https://doi.org/10.30773/pi.2020.0058 
  19. Phan T. (2020). Genetic diversity and evolution of SARS-CoV-2.  Infection, Genetics & Evolution, 104260. doi:10.1016/j.meegid.2020.104260, https://doi.org/10.1016/j.meegid.2020.104260 (需訂閱)
  20. Song P & Karako T. (2020). COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern.  Bioscience Trends, doi:10.5582/bst.2020.01056, https://doi.org/10.5582/bst.2020.01056 
  21. Sun P, Lu X, Xu C, Sun W & Pan B. (2020). Understanding of COVID-19 based on current evidence.  Journal of Medical Virology, doi:10.1002/jmv.25722, https://doi.org/10.1002/jmv.25722 
  22. Tetro JA. (2020). Is COVID-19 Receiving ADE From Other Coronaviruses?.  Microbes & Infection, doi:10.1016/j.micinf.2020.02.006, https://doi.org/10.1016/j.micinf.2020.02.006 
  23. Totura AL & Bavari S. (2019). Broad-spectrum coronavirus antiviral drug discovery.  Expert Opinion on Drug Discovery, 14, 397-412. doi:10.1080/17460441.2019.1581171, https://doi.org/10.1080/17460441.2019.1581171 
  24. Trilla A. (2020). One world, one health: The novel coronavirus COVID-19 epidemic.  Medicina Clinica, doi:10.1016/j.medcli.2020.02.002, https://doi.org/10.1016/j.medcli.2020.02.002 (需訂閱)
  25. Wang J, Liu J, Wang Y, Liu W, Chen X, Sun C, et al. (2020). 2019冠狀病毒病（COVID-19）患者胸部CT影像學動態變化 [Dynamic changes of chest CT imaging in patients with corona virus disease-19 (COVID-19)].  Zhejiang da Xue Xue Bao. Yi Xue Ban/Journal of Zhejiang University. Medical Sciences, 49(1), 0. doi:10.3785/j.issn.1008-9292.2020.02.03, http://www.zjujournals.com/med/article/2020/1008-9292/20200103.shtml
  26. Wang Y, Kang H, Liu X & Tong Z. (2020). Combination of RT-qPCR Testing and Clinical Features For Diagnosis of COVID-19 facilitates management of SARS-CoV-2 Outbreak.  Journal of Medical Virology, doi:10.1002/jmv.25721, https://doi.org/10.1002/jmv.25721 
  27. Wen X & Li Y. (2020). Anesthesia Procedure of Emergency Operation for Patients with Suspected or Confirmed COVID-19.  Surgical Infections, doi:10.1089/sur.2020.040, https://doi.org/10.1089/sur.2020.040 (需訂閱)
  28. Xiao C. (2020). A Novel Approach of Consultation on 2019 Novel Coronavirus (COVID-19)-Related Psychological and Mental Problems: Structured Letter Therapy.  Psychiatry Investigation, 17, 175-176. doi:10.30773/pi.2020.0047, https://doi.org/10.30773/pi.2020.0047 
  29. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa.  International Journal of Oral Science, 12, 8. doi:10.1038/s41368-020-0074-x, https://doi.org/10.1038/s41368-020-0074-x 
  30. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. (2020). 2019冠狀病毒病（COVID-19）診療浙江經驗 [Management of corona virus disease-19 (COVID-19): the Zhejiang experience].  Zhejiang da Xue Xue Bao. Yi Xue Ban/Journal of Zhejiang University. Medical Sciences, 49(1), 0. doi:10.3785/j.issn.1008-9292.2020.02.02, http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.02.02
  31. Zhang J, Ma K, Li H, Liao M & Qi W. (2020). The continuous evolution and dissemination of 2019 novel human coronavirus.  Journal of Infection, doi:10.1016/j.jinf.2020.02.001, https://doi.org/10.1016/j.jinf.2020.02.001 (需訂閱)
  32. Zhao L, Zhang L, Liu JW, Yang ZF, Shen WZ & Li XR. (2020). 新型冠狀病毒肺炎疫情嚴重地區乳腺疾病患者的管理策略 [The treatment proposal for the patients with breast diseases in the central epidemic area of 2019 coronavirus disease].  Chung-Hua Wai Ko Tsa Chih [Chinese Journal of Surgery], 58, E005. doi:10.3760/cma.j.cn112139-20200221-00116, https://doi.org/10.3760/cma.j.cn112139-20200221-00116 
  33. Zhao S, Zhuang Z, Ran J, Lin J, Yang G, Yang L, et al. (2020). The association between domestic train transportation and novel coronavirus (2019-nCoV) outbreak in China from 2019 to 2020: A data-driven correlational report.  Travel Medicine & Infectious Disease, 33, 101568. doi:10.1016/j.tmaid.2020.101568, https://doi.org/10.1016/j.tmaid.2020.101568 
  34. Zhu Y, Chen L, Ji H, Xi M, Fang Y & Li Y. (2020). The Risk and Prevention of Novel Coronavirus Pneumonia Infections Among Inpatients in Psychiatric Hospitals.  Neuroscience Bulletin, doi:10.1007/s12264-020-00476-9, https://doi.org/10.1007/s12264-020-00476-9 

留言

張貼留言